VF
HOWL icon

Virtu Financial’s Werewolf Therapeutics HOWL Stock Holding History

Virtu Financial’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,230
Closed -$24K – 1892
2025
Q3 		$24K Buy
+12,230
New +$16.7K ﹤0.01% 1254
2024
Q1 		– Sell
-20,383
Closed -$79K – 1691
2023
Q4 		$79K Buy
+20,383
New +$52.1K 0.01% 1076

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial's HOWL Position: Q4 2025 in Review

Virtu Financial sold out of Werewolf Therapeutics (HOWL) in Q4 2025, closing a stake of 12,230 shares — an estimated $24K sold.

Virtu Financial first reported a position in HOWL in Q4 2023 and held it in 2 quarters. The position peaked at $79K in Q4 2023. 51 funds tracked by Wall St. Rank hold HOWL as of Q4 2025.

  • Virtu Financial reported no remaining Werewolf Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 12,230 Werewolf Therapeutics shares in Q4 2025, an estimated $24K.
  • Virtu Financial first reported a position in Werewolf Therapeutics in Q4 2023 and held it in 2 quarters.
  • Virtu Financial's Werewolf Therapeutics position peaked at $79K in Q4 2023.
  • 51 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.